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Introduction
Mycobacteria that infect and cause disease in cats include 
tuberculous mycobacteria (Mycobacterium bovis, 
Mycobacterium microti and Mycobacterium tuberculosis); 
opportunistic, non-tuberculous mycobacteria (NTM), 
which include slow-growing species such as 
Mycobacterium avium and rapidly growing species such 
as Mycobacterium fortuitum and Mycobacterium smegmatis; 
and lepromatous mycobacteria, which are fastidious or 
unculturable species that cause nodular pyogranuloma-
tous inflammatory lesions (feline leprosy syndrome).1 
The prevalence of mycobacterial infections in cats world-
wide varies. Feline leprosy syndrome and NTM appear 
to be relatively common in Australia and parts of the 
USA, while tuberculosis (TB; due to M bovis), feline 
leprosy syndrome and NTM are regularly diagnosed in 
New Zealand and the UK (M bovis and M microti).1
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Abstract
Case summary A domestic shorthair cat was evaluated for chronic, bilateral, ulcerative dermatitis affecting the 
inguinal region and lateral aspects of both pelvic limbs. Histopathologic examination of skin biopsies collected 
throughout the course of disease revealed chronic pyogranulomatous ulcerative dermatitis. Aerobic bacterial skin 
cultures yielded growth of a methicillin-resistant Staphylococcus aureus and Corynebacterium amycolatum. Upon 
referral the clinical findings were suggestive of a non-tuberculous Mycobacterium species infection. Previously 
obtained skin cultures failed to yield growth of mycobacterial organisms. A deep skin biopsy was collected and 
submitted for mycobacterial culture. At 5 weeks of incubation Mycobacterium thermoresistibile was isolated. In 
previous reports, M thermoresistibile has been isolated after 2–4 days of incubation, suggesting that this strain 
may have been a slower growing variant, or other factors (such as prior antimicrobial therapy) inhibited rapid 
growth of this isolate. The cat was hospitalized for intravenous antibiotic therapy, surgical debridement of wounds, 
vacuum-assisted wound closure therapy and reconstruction procedures. The wounds were ultimately primarily 
closed and the cat was discharged to the owner after 50 days of hospitalization. Seven months after hospitalization, 
the ulcerative skin lesions had healed.
Relevance and novel information To our knowledge, only two cases of M thermoresistibile panniculitis have been 
reported in cats. In the only detailed report of feline M thermoresistibile panniculitis, treatment was not attempted. 
The second case only reported detection of M thermoresistibile by PCR without a clinical description of the case. 
In our case report, severe chronic skin infection with M thermoresistibile was addressed using prolonged specific 
antibiotic therapy, surgical debridement and reconstructions, and treatment of secondary bacterial infections.
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Mycobacterial panniculitis refers to the clinical syn-
drome characterized by chronic infection of the subcutis 
and skin of cats by NTM. In cats, disease typically fol-
lows contamination of wounds. The bacterial species 
involved appear to have a predilection for adipose tis-
sue.1 Rapidly growing mycobacteria are a heterogene-
ous group of organisms that produce visible colonies on 
synthetic media within 5 days when cultured at room 
temperature. They are distributed ubiquitously in 
nature, and can be isolated commonly from soil and 
bodies of water.2 Commonly isolated bacteria in this 
group include M fortuitum, M smegmatis, Mycobacterium 
chelonae and Mycobacterium abscessus.3 Mycobacterium 
thermoresistibile is an NTM that is rarely reported in 
human and animal infections.2,4,5 To our knowledge, 
only eight cases of human infection and three cases of 
feline infection have been reported in the literature.2,6–8 
Half of the infections in people occurred 3 months after 
surgery.2,4 The three previously reported cases of M ther-
moresistibile infections in cats included two cats with 
skin infections,5,7 and one with pneumonia.5,6 One cat 
with M thermoresistibile panniculitis was reported from 
the Netherlands in 1985. That cat was euthanized imme-
diately after diagnosis.7 The other case of M thermore-
sistibile feline panniculitis was reported as part of a case 
series, where identification of infecting mycobacteria 
was performed using PCR on archived cytology slides. 
More details about this case were not described.5 The cat 
with M thermoresistibile pneumonia was treated empiri-
cally with multiagent antibiotic therapy that consisted 
of doxycycline, rifampicin and clarithromycin.6 That cat 
made a clinical recovery, despite the persistence of 
abnormal findings on thoracic radiographs, and anti-
biotics were discontinued after 1 year of treatment.6  
In humans with NTM, therapy of 3–24 months’ 
duration is recommended.9 Currently, no published 
recommendations exist for the treatment of M ther-
moresistibile infections for feline patients. Here we 
report a cat with severe mycobacterial panniculitis 
caused by M thermoresistibile and the approach to treat-
ment of the infection. To our knowledge, this is the first 
report of this infection in companion animals in North 
America.
Case description
A 6-year-old, male, neutered, domestic shorthair cat was 
first evaluated by a referring veterinarian in January 
2015 for an ulcerated skin wound in the inguinal area 
that was suspected to be a fight wound. The cat was 
treated with two injections of cefovecin over the subse-
quent 6 months. The ulcers waxed and waned in size 
and depth. In July 2015, a swab specimen was obtained 
from the affected skin. Aerobic and anaerobic bacterial 
culture yielded Actinomyces species, Corynebacterium 
species and Pasteurella species. Treatment with clavulanic 
acid-amoxicillin (15 mg/kg PO q12h for 2 weeks) did not 
result in clinical improvement.
The cat was referred to the Dermatology Service at the 
University of California-Davis in August 2015 (7 months 
after original wound appearance). Histopathologic 
examination of a punch skin biopsy from the inguinal 
region at that time revealed severe, chronic, ulcerative, 
multifocal-to-coalescing, pyogranulomatous, deep der-
matitis and panniculitis. No infectious organisms were 
evident on sections stained by hematoxylin and eosin 
stain, Brown and Brenn gram stain, Ziehl–Neelsen acid-
fast stain, Grocott-Gomori’s methenamine silver stain, 
periodic acid–Schiff stain and Giemsa stain. The cat was 
treated with marbofloxacin (4.6 mg/kg PO q24h) for 
suspected mycobacterial infection and oral amoxicillin 
(37 mg/kg PO q12h) for suspected secondary bacterial 
infection, pending the results of aerobic and anaerobic 
bacterial culture and susceptibility of a macerated skin 
biopsy specimen, fungal culture of the biopsy specimen 
and aerobic bacterial culture of a swab from a draining 
tract. Subsequently, culture of the skin biopsy yielded 
growth of small numbers of a Corynebacterium species, 
and culture of the draining tract yielded growth of 
Corynebacterium amycolatum and a methicillin-resistant 
Staphylococcus aureus (MRSA). The identity of C amycola-
tum was determined using matrix-assisted laser deioni-
zation–time of flight mass spectrometry and confirmed 
by 16S rRNA gene PCR and sequencing of the 574-base 
pair product. The C amycolatum isolate was susceptible 
to gentamicin, amikacin, chloramphenicol, clindamycin, 
doxycycline, erythromycin and trimethoprim sulfameth-
oxazole; had intermediate susceptibility to imipenem; 
and was resistant to amoxicillin–clavulanic acid and 
cefazolin. The minimum inhibitory concentration for 
enrofloxacin and marbofloxacin was ⩽0.25 μg/ml (no 
breakpoint available). The MRSA was susceptible to 
amikacin, chloramphenicol, clindamycin and trimetho-
prim sulfamethoxazole, and resistant to beta(β)-lactams, 
fluoroquinolones, erythromycin and rifampin. Anaerobic 
and fungal culture yielded no growth. Given these 
results and continued clinical suspicion for mycobacte-
rial panniculitis, fluoroquinolone treatment (marbo-
floxacin 4.6 mg/kg PO q24h) was recommended in 
combination with trimethoprim sulfamethoxazole (22 
mg/kg PO q12h, dose listed for combined components 
of sulfamethoxazole and trimethoprim at a ratio of 5:1). 
An Elizabethan collar was placed to prevent the cat from 
licking its wounds.
The owner was not able to prevent the cat from 
removing the Elizabethan collar or to administer consist-
ently the antibiotics at home, and so the cat was brought 
to the Internal Medicine Service for re-evaluation in 
October 2015 (9 months after original wound appear-
ance and 2 months after the first evaluation by the 
Dermatology Service). At that time, the cat was admitted 
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to the Veterinary Medical Teaching Hospital (VMTH) for 
wound care due to progression of lesions. On physical 
examination, the cat was alert and responsive and in 
good body condition (score 5/9) with normal vital signs. 
The cat was non-ambulatory and assessed to be painful 
in the pelvic limbs. Within the inguinal region there were 
deep skin wounds that were 25 cm × 15 cm. A large 
amount of purulent exudate discharged from the 
wounds. An ulcerated, 10 cm × 5 cm lesion with exudate 
and crusts was present on the lateral aspect of the right 
thigh.
A complete blood count showed mild normocytic 
normochromic anemia with a hematocrit of 26.3% (refer-
ence interval [RI] 30–50%). A serum chemistry panel 
showed mild hyperphosphatemia (7.1 mg/dl; RI 3.2–6.3 
mg/dl), mild hyperglycemia of 198 mg/dl (RI 63–118 
mg/dl) and a mildly increased creatine kinase concen-
tration of 408 U/l (RI 73–260 U/l). The cat was negative 
for feline immunodeficiency virus antibodies and feline 
leukemia virus antigen (SNAP; IDEXX Laboratories). 
Aerobic bacterial blood cultures (two samples of 3 ml 
each, collected from each jugular vein) yielded no 
growth. Thoracic radiographs were unremarkable.
The cat’s wounds were cleaned and debrided under 
general anesthesia (Figures 1 and 2). A vacuum-assisted 
wound closure device was used to treat the inguinal 
wounds, as previously described,10 to assist with healing 
and skin apposition (Figure 3). The right lateral thigh 
wounds were debrided and treated with wet-to-dry 
bandaging. An esophagostomy tube was placed to facili-
tate administration of medications.
Histopathologic examination of a punch biopsy 
(6 mm in diameter) again revealed severe, chronic, mul-
tifocal, pyogranulomatous dermatitis and panniculitis 
and granulomatous lymphangitis (Figures 4 and 5). No 
infectious organisms were identified after staining with 
Ziehl–Neelsen acid-fast stain, Giemsa, Brown and Brenn 
gram stain and Grocott-Gomori’s methenamine silver 
stain. Tissue PCR for a M tuberculosis–bovis complex 
(MTBC) organism was weakly positive after 40 cycles of 
PCR (cycle threshold [CT] values 36.57 for Mycobacterium 
species DNA and 20.91 for the housekeeping gene, with 
values <40 being positive). This assay detects the rpoB 
gene of M bovis, Mycobacterium caprae, M tuberculosis and 
M microti.
The skin biopsy specimens were also submitted to the 
VMTH microbiology laboratory for aerobic and anaero-
bic bacterial cultures and a fungal culture. A skin biopsy 
specimen was also submitted for mycobacterial culture 
Figure 1 Inguinal region at time of hospitalization (October 
2015) and prior to wound debridement
Figure 2 Right lateral thigh at time of hospitalization (October 
2015) and prior to wound debridement
Figure 3 Vacuum-assisted wound closure device applied 
after wound debridement (October 2015)
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and ribosomal RNA gene PCR for MTBC at Advanced 
Diagnostic Laboratory Services, National Jewish Health, 
Denver, CO. The MTBC PCR results were reported 3 
days later as negative.
Pending the results of the tests listed above, the cat 
was treated with doxycycline monohydrate suspension 
(10 mg/kg q12h, followed by 5 ml water through the 
esophagostomy tube) and vancomycin (15 mg/kg IV 
q8h). The doxycycline was selected based on our previ-
ous success with doxycycline at this dose to treat myco-
bacterial panniculitis. Although a controversial choice, 
vancomycin was selected pending culture and suscepti-
bility test results based on the history of isolation of 
MRSA and C amycolatum, the need for a parenteral anti-
microbial drug, the severity of the lesions and concern 
for multidrug resistance in the light of the history of 
treatment with fluoroquinolones, β-lactams and tri-
methoprim sulfamethoxazole. Pain was managed with 
buprenorphine at 0.01 mg/kg intravenously every 4–6 h 
for the first 2 weeks of hospitalization and then via the 
sublingual route. Within several days of starting therapy 
the cat developed anorexia, apparent nausea, lethargy 
and acute elevations in the activity of serum liver 
enzymes (alanine aminotransferase 939 U/l [RI 27–101 
U/l], aspartate aminotransferase 290 U/l [RI 17–58 U/l], 
alkaline phosphatase 125 U/l [RI 14–71 U/l]) and an 
increase in serum bilirubin concentration (1.4 mg/dl [RI 
0–0.2 mg/dl]). The hepatopathy was suspected to be an 
adverse reaction to doxycycline. Doxycycline treatment 
was discontinued and the hepatopathy resolved. In 
place of the doxycycline, treatment with pradofloxacin 
(7.5 mg/kg PO q24h) was initiated.11
The skin cultures performed at the University of 
California-Davis microbiology laboratory again yielded 
MRSA and C amycolatum. The MRSA was susceptible to 
gentamicin, amikacin, chloramphenicol, clindamycin, 
doxycycline, rifampin, trimethoprim sulfamethoxazole, 
daptomycin, vancomycin and linezolid but resistant to 
erythromycin and fluoroquinolones. The C amycolatum 
isolate was susceptible to chloramphenicol, doxycycline 
and vancomycin but resistant to aminoglycosides, 
β-lactams, clindamycin, erythromycin, trimethoprim 
sulfamethoxazole, fluoroquinolones, linezolid and 
rifampin. Treatment was therefore continued with par-
enteral vancomycin (for its activity against both the 
MRSA and Corynebacterium species isolates) and prado-
floxacin (for presumed mycobacterial infection).
The vacuum-assisted wound closure system remained 
in place, in the inguinal area, for the first 2 weeks of 
 hospitalization with wound evaluation and bandage 
Figure 4 Subgross image of histopathology slide prepared 
from one skin biopsy sample. Nodular foci of granulomatous 
inflammation (black arrows) are scattered throughout the 
deep aspect of the dermis and the panniculus adiposus. 
Some foci are more heavily populated by lymphocytes and 
plasma cells (open arrows). A band of immature connective 
tissue (arrowheads) subtends the deep aspect of the dermis, 
and is presumably a response to the chronic inflammation. 
Hematoxylin and eosin stain. Scale bar = 1 mm
Figure 5 Detail of granulomatous infiltrates evident in 
biopsy samples. Epithelioid macrophages (arrows) were the 
dominant inflammatory cell type in most affected regions. Foci 
of necrotic tissue (bracket) with darkly stained eosinophilic 
cells, and cell debris were scattered throughout many  
regions of inflammation. Hematoxylin and eosin stain.  
Scale bar = 40 µm
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changes in both the inguinal area and the right lateral 
thigh every 2–3 days. Thirty days after admission, the 
wounds were closed in a staged manner involving two 
separate surgeries spaced 2 weeks apart. After hospitali-
zation for 50 days, vancomycin was discontinued and 
the cat was discharged on oral pradofloxacin.
Four weeks after skin biopsy submission for mycobac-
terial culture in liquid medium, growth of M thermore-
sistibile was identified by the reference laboratory. The 
organism was identified using rpoB gene PCR sequenc-
ing. Antimicrobial susceptibility test results of M ther-
moresistibile became available 7 weeks from submission 
and the organism was reported to be susceptible to all 
antimicrobials tested (aminoglycosides, third-generation 
cephalosporins, imipenem, ciprofloxacin, moxifloxacin, 
doxycycline, clarithromycin, azithromycin, clavulanic 
acid–amoxicillin, trimethoprim sulfamethoxazole, clofa-
zimine and linezolid).
Treatment with pradofloxacin was continued, but 
owing to the appearance of new wounds 3 weeks after 
discharge, clarithromycin (7 mg/kg PO q12h) and tri-
methoprim sulfamethoxazole (30 mg/kg PO q12h) were 
added to the antibiotic regimen. To overcome owner 
compliance concerns, the cat was housed at a medical 
boarding facility for 2 months. Dehiscence occurred at 
the surgical closure site in the inguinal region and was 
allowed to slowly heal by secondary intention (Figure 6). 
Sixteen months after original wound appearance and 7 
months after hospitalization, the ulcerative skin lesions 
had healed completely and the cat had returned to nor-
mal activity. Several small firm subcutaneous nodules 
remained palpable on both sides of the abdominal body 
wall which appeared to be slowly reducing in size and 
number.
Discussion
Mycobacterial panniculitis in cats caused by non-tubercu-
lous mycobacterial species has been well described in the 
literature.3,12 One case report of M thermoresistibile pneu-
monia treatment exists in the literature. However, to the 
best of our knowledge, this is only the third report of 
mycobacterial panniculitis caused by M thermoresistibile in 
cats and the first report of attempted treatment of M ther-
moresistibile panniculitis.5,7 The extent and severity of dis-
ease in this cat likely reflected a combination of delayed 
diagnosis and problems with owner compliance.
In human medicine it has been hypothesized that 
traumatic inoculation with M thermoresistibile present in 
soil results in local infection,2 which may also have been 
the case in this cat with outdoor exposure. Mycobacterial 
infection was strongly suspected in this cat despite fail-
ure to isolate a mycobacterial species owing to clinical 
presentation and histopathology. The positive result on 
PCR for an MTBC organism in our laboratory was a con-
cern because of the zoonotic potential of organisms 
belonging to this complex. However, the clinical presen-
tation combined with the high CT value raised suspicion 
for a false-positive result, and upon discussion of the 
result with the laboratory, it was revealed that the prim-
ers used had the potential to amplify DNA from 
Mycobacterium species that do not belong to the MTBC. 
In previous reports, M thermoresistibile has been isolated 
after 2–4 days of incubation, suggesting that this strain 
may have been a slower-growing variant, or other fac-
tors (such as prior antimicrobial therapy) inhibited rapid 
growth of this isolate.
M thermoresistibile was first isolated from soil and 
house dust in Japan in 1966.9 For many years M thermore-
sistibile was considered non-pathogenic, but in the past 
20 years cases demonstrating its pathogenicity have 
been described in people and cats; cases have been 
reported from Asia, Europe and North America.2,4,9  
M thermoresistibile is also unusual in that it is thermotol-
erant, growing optimally at temperatures between 
37°C and 52°C.6,8 In people, reports of infection with 
M thermoresistibile have been associated with postsurgi-
cal infection (in a few of those implants were involved) 
in skin and lungs.2 The majority of infected patients are 
immunocompromised, as is often true in other NTM 
infections in humans.2 This, to our knowledge, is the first 
report of infection by M thermoresistibile in a cat in North 
America. It is possible that the paucity of previous 
reports of infections due to M thermoresistible in cats may 
result from lack of full identification of the causative 
organism in some infections.
Two other bacterial species, C amycolatum and 
S aureus, were also isolated from the wounds of the cat in 
Figure 6 Inguinal area 3 months after hospitalization (January 
2016)
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this case report. Both are components of the normal flora 
of normal human and animal skin and mucous mem-
branes.13,14 However, they can also be pathogenic in 
some circumstances. In particular, C amycolatum is 
increasingly being recognized as an important pathogen 
of humans with multidrug resistance to commonly used 
antibiotics, although it is typically susceptible to vanco-
mycin.13,15 Over the course of the disease process, C amy-
colatum was isolated from the cat in this report four 
times, despite antimicrobial therapy, and likely contrib-
uted to the severity of the wounds in this cat. Given that 
S aureus can normally colonize cat skin,16 the significance 
of the S aureus isolate was less clear, but it may also have 
played a role in secondary infection.
We ultimately chose pradofloxacin for long-term ther-
apy of the mycobacterial infection, a third-generation 
fluoroquinolone licensed in the USA at a dose of 7.5 mg/
kg for treatment of skin infections in the cat. Pradofloxacin 
possesses an extended spectrum of activity against 
gram-negative, gram-positive and anaerobic bacteria, 
as well as mycoplasma species and intracellular organ-
isms (Rickettsia species and Mycobacterium species).11,17 
Specifically, pradofloxacin has demonstrated effective in 
vitro activity against rapid growing mycobacteria iso-
lates.17 Although M thermoresistibile was not tested for 
susceptibility for pradofloxacin, it was susceptible to 
moxifloxacin, a human fluoroquinolone that is the chemi-
cal equivalent of pradofloxacin.17 The choice of vancomy-
cin to address the secondary infections in this case was 
controversial given concerns about use of this antibiotic 
in animals. However, vancomycin was chosen because 
vancomycin is the drug of choice for MRSA and resistant 
Corynebacterium species infections in humans, both the 
MRSA and the multidrug-resistant Corynebacterium spe-
cies isolates in this case had documented susceptibility, 
and no alternative single bactericidal antimicrobial could 
be identified that could be given parenterally with a wide 
therapeutic index. It is possible that a shorter duration of 
therapy might also have been sufficient, but given the 
multiple surgeries required and the extent and depth of 
the infected wounds, the decision was made to continue 
to treat until surgery had been completed and the cat 
could be discharged from the hospital.
Conclusions
To our knowledge, this is the first case report of the 
treatment of M thermoresistibile panniculitis in a cat and 
the first report of infection with this organism in cats in 
North America. It is also the first report, to our knowl-
edge, of cutaneous infection with C amycolatum in a cat. 
If clinical presentation is consistent with a mycobacte-
rial infection, appropriate samples should be submitted 
for mycobacterium growth and identification, even if 
other bacterial species have been isolated from the 
patient. Successful isolation of some mycobacterial spe-
cies may require prolonged incubation at institutions 
with expertise in isolation of mycobacteria. Despite inten-
sive wound management and combination therapy with 
antimicrobial drugs, in addition to efforts to ensure client 
compliance, resolution of severe mycobacterial panniculi-
tis caused by M thermoresistibile may not be possible, 
although additional studies are required to support this 
observation.
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